Goals

  • Improve diagnostic, predictive and monitoring modalities and prevent disease progression.
  • Develop novel targeted forms of treatment, both immunological (antibody/DC vaccines/CART/NK) and chemical (PROTACS, small molecules) and perform investigator-initiated phase I/II trials.
  • Improve quality of life by reducing early and late treatment-related toxicity and avoiding disease progression.
  • Enhance patient engagement and shared decision making by personalized, eHealth-based care platforms.


Research Research programs Treatment improvement for severe hematological diseases

Our purpose

We aim to unravel the pathophysiological basis of hematological disease, understand the biological consequences and define possibilities for therapeutic intervention.


Goals

See some of the most important goals for this research program.

read more

Research groups contributing to this research program

Spokesperson(s) for this research program


Spokesperson

dr. Bert van der Reijden

contact form